Flavonoids exert potential in the management of hypertensive disorders in pregnancy.
Flavonoids
Hypertensive disorders
Preeclampsia
Pregnancy
Journal
Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
06
06
2022
accepted:
29
06
2022
pubmed:
9
7
2022
medline:
10
8
2022
entrez:
8
7
2022
Statut:
ppublish
Résumé
Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.
Identifiants
pubmed: 35803199
pii: S2210-7789(22)00064-2
doi: 10.1016/j.preghy.2022.06.007
pii:
doi:
Substances chimiques
Flavonoids
0
Tea
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
72-85Informations de copyright
Copyright © 2022. Published by Elsevier B.V.